MEDICAL PROPERTIES TRUST INC Earnings Per Share Disclosure
Medical Properties Trust, Inc.
Our earnings per share were calculated based on the following (in thousands):
|
|
For the Years Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Numerator: |
|
|
|
|
|
|
|
|
|
|||
Net loss |
|
$ |
(275,937 |
) |
|
$ |
(2,408,287 |
) |
|
$ |
(556,092 |
) |
Non-controlling interests’ share in earnings |
|
|
(1,112 |
) |
|
|
(1,984 |
) |
|
|
(384 |
) |
Participating securities’ share in earnings |
|
|
(889 |
) |
|
|
(946 |
) |
|
|
(1,644 |
) |
Net loss, less participating securities’ share in |
|
$ |
(277,938 |
) |
|
$ |
(2,411,217 |
) |
|
$ |
(558,120 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|||
Basic weighted-average common shares |
|
|
600,892 |
|
|
|
600,248 |
|
|
|
598,518 |
|
Dilutive potential common shares(1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Diluted weighted-average common shares |
|
|
600,892 |
|
|
|
600,248 |
|
|
|
598,518 |
|
MPT Operating Partnership, L.P.
Our earnings per unit were calculated based on the following (in thousands):
|
|
For the Years Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Numerator: |
|
|
|
|
|
|
|
|
|
|||
Net loss |
|
$ |
(275,937 |
) |
|
$ |
(2,408,287 |
) |
|
$ |
(556,092 |
) |
Non-controlling interests’ share in earnings |
|
|
(1,112 |
) |
|
|
(1,984 |
) |
|
|
(384 |
) |
Participating securities’ share in earnings |
|
|
(889 |
) |
|
|
(946 |
) |
|
|
(1,644 |
) |
Net loss, less participating securities’ share in |
|
$ |
(277,938 |
) |
|
$ |
(2,411,217 |
) |
|
$ |
(558,120 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|||
Basic weighted-average units |
|
|
600,892 |
|
|
|
600,248 |
|
|
|
598,518 |
|
Dilutive potential units(1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Diluted weighted-average units |
|
|
600,892 |
|
|
|
600,248 |
|
|
|
598,518 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Mar 1, 2022 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.